[1]
Rahmani, T.P., Harahap, Y. and Purwanto, D.J. 2024. A review of the relationship between Doxorubicin and Doxorubicinol, CBR1 polymorphism, and cardiotoxicity. Pharmacy Education. 24, 6 (Jun. 2024), p. 105–115. DOI:https://doi.org/10.46542/pe.2024.246.105115.